The original success of Viagra undeniably transformed the medication landscape, but placing funds in companies primarily reliant on unbranded versions presents a complex picture. Despite early returns were impressive, the expiration of patents and the appearance of cheaper alternatives have diminished sales. Consequently, a thorough assessment of p